Fig. 3From: Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugsClassification of dose-response trials. Upper panel: Classification of the dose-response trials conducted in Japan. Lower panel: Classification of the dose-response trials conducted outside of Japan. The numbers in the figure are the numbers of drugsBack to article page